A systematic stochastic design strategy achieving an optimal tradeoff between peak BGL and probability of hypoglycaemic events for individuals having type 1 diabetes mellitus

Abstract This paper has two key contributions. The first contribution is a systematic procedure for fitting an envelope of models which captures a range of possible blood glucose level (BGL) responses for a particular individual having Type 1 diabetes. An important aspect of the procedure is that it requires minimal testing on the individual. Moreover, the testing can be carried out by the individual at home. The developed envelope of models, termed ‘Metabolic Digital Twin Envelope’ (MDTE) takes into account the quantification of possible errors including those arising from utilising a simplified model (commonly called “bias” errors) and those arising from unmodelled disturbances and noise (commonly called “variance” errors). The second, and most important, contribution is a methodology that allows convex optimisation to be used to develop an insulin injection policy which minimises mean square peak BGL whilst ensuring that there is a strict lower bound on the probability of hyperglycaemic events. The optimisation methodology is posed as a stochastic design strategy based on using the probabilistic models for each individual afforded by the MDTE.

[1]  J. Geoffrey Chase,et al.  A 3D insulin sensitivity prediction model enables more patient-specific prediction and model-based glycaemic control , 2018, Biomed. Signal Process. Control..

[2]  C. Cobelli,et al.  The UVA/PADOVA Type 1 Diabetes Simulator , 2014, Journal of diabetes science and technology.

[3]  Richard D. Braatz,et al.  Stochastic model predictive control with joint chance constraints , 2015, Int. J. Control.

[4]  Graham C. Goodwin,et al.  Control System Design , 2000 .

[5]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[6]  Christopher E. Hann,et al.  A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients , 2011, Comput. Methods Programs Biomed..

[7]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..

[8]  Giovanni Sparacino,et al.  Improving Accuracy and Precision of Glucose Sensor Profiles: Retrospective Fitting by Constrained Deconvolution , 2014, IEEE Transactions on Biomedical Engineering.

[9]  Henrik Ohlsson,et al.  On the estimation of transfer functions, regularizations and Gaussian processes - Revisited , 2012, Autom..

[10]  L. Magni,et al.  Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home , 2016, Diabetes Care.

[11]  J. Geoffrey Chase,et al.  STAR Development and Protocol Comparison , 2012, IEEE Transactions on Biomedical Engineering.

[12]  David C. Klonoff,et al.  Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital , 2018, Diabetes Care.

[13]  Graham C. Goodwin,et al.  Non-stationary stochastic embedding for transfer function estimation , 1999, Autom..

[14]  Pu Li,et al.  Advances and applications of chance-constrained approaches to systems optimisation under uncertainty , 2013, Int. J. Syst. Sci..

[15]  Patricio Colmegna,et al.  Analysis of three T1DM simulation models for evaluating robust closed-loop controllers , 2014, Comput. Methods Programs Biomed..

[16]  Giuseppe De Nicolao,et al.  MPC based Artificial Pancreas: Strategies for individualization and meal compensation , 2012, Annu. Rev. Control..

[17]  J. Geoffrey Chase,et al.  Stochastic Targeted (STAR) Glycemic Control: Design, Safety, and Performance , 2012, Journal of diabetes science and technology.

[18]  Garry M. Steil,et al.  Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[19]  Josep Vehí,et al.  A review of personalized blood glucose prediction strategies for T1DM patients , 2017, International journal for numerical methods in biomedical engineering.

[20]  Patricio Colmegna,et al.  Linear parameter-varying model to design control laws for an artificial pancreas , 2018, Biomed. Signal Process. Control..

[21]  Levente Kovács,et al.  Induced L2-norm minimization of glucose-insulin system for Type I diabetic patients , 2011, Comput. Methods Programs Biomed..

[22]  Claudio Cobelli,et al.  Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results , 2018, IEEE Transactions on Biomedical Engineering.

[23]  Malgorzata E. Wilinska,et al.  Modeling Day-to-Day Variability of Glucose–Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery , 2017, IEEE Transactions on Biomedical Engineering.

[24]  Alexander Shapiro,et al.  Lectures on Stochastic Programming: Modeling and Theory , 2009 .

[25]  Ahmad Haidar,et al.  Stochastic Virtual Population of Subjects With Type 1 Diabetes for the Assessment of Closed-Loop Glucose Controllers , 2013, IEEE Transactions on Biomedical Engineering.

[26]  Tianshi Chen,et al.  A shift in paradigm for system identification , 2019, Int. J. Control.

[27]  Jeroen van den Hoven,et al.  Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm , 2018, Front. Genet..

[28]  Lalo Magni,et al.  Glucose-insulin model identified in free-living conditions for hypoglycaemia prevention , 2018 .

[29]  P. McElduff,et al.  Optimizing the combination insulin bolus split for a high‐fat, high‐protein meal in children and adolescents using insulin pump therapy , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[30]  R. Hovorka,et al.  Simulation models for in silico testing of closed-loop glucose controllers in type 1 diabetes , 2008 .

[31]  Guido Freckmann,et al.  Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison , 2019, Journal of diabetes science and technology.

[32]  Eyal Dassau,et al.  Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes , 2016, Autom..

[33]  Christopher G. Pretty,et al.  Estimation of the insulin sensitivity profile for the stochastic variant of the ICING model , 2016, 2016 IEEE 20th Jubilee International Conference on Intelligent Engineering Systems (INES).

[34]  Eyal Dassau,et al.  Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance , 2018, Autom..

[35]  Elena Toschi,et al.  Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management , 2016, Diabetes Care.

[36]  Christopher G. Pretty,et al.  Analysis of Stochastic Noise of Blood-Glucose Dynamics , 2017 .

[37]  Claude H. Moog,et al.  A Long-Term Model of the Glucose–Insulin Dynamics of Type 1 Diabetes , 2015, IEEE Transactions on Biomedical Engineering.

[38]  Patrick McElduff,et al.  Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy , 2014, BMJ Open Diabetes Research and Care.

[39]  Tor Arne Johansen,et al.  On Tikhonov regularization, bias and variance in nonlinear system identification , 1997, Autom..

[40]  Lennart Ljung,et al.  System Identification: Theory for the User , 1987 .

[41]  Yeong Shiong Chiew,et al.  Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them , 2018, BioMedical Engineering OnLine.

[42]  Graham C. Goodwin,et al.  Dynamic System Identification: Experiment Design and Data Analysis , 2012 .

[43]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[44]  Lennart Ljung,et al.  Model Error Modeling and Stochastic Embedding , 2015 .

[45]  Richard D. Braatz,et al.  Stochastic model predictive control with joint chance constraints , 2015, Int. J. Control.

[46]  Eyal Dassau,et al.  Switched LPV Glucose Control in Type 1 Diabetes , 2016, IEEE Transactions on Biomedical Engineering.

[47]  Boris Kovatchev,et al.  Analysis, Modeling, and Simulation of the Accuracy of Continuous Glucose Sensors , 2008, Journal of diabetes science and technology.

[48]  Levente Kovcs,et al.  Linear parameter varying (LPV) based robust control of type-I diabetes driven for real patient data , 2017 .

[49]  Claudio Cobelli,et al.  Artificial Pancreas: Model Predictive Control Design from Clinical Experience , 2013, Journal of diabetes science and technology.

[50]  Claudio Cobelli,et al.  One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator , 2016, IEEE Transactions on Biomedical Engineering.

[51]  Graham C. Goodwin,et al.  Estimated Transfer Functions with Application to Model Order Selection , 1992 .

[52]  Claudio Cobelli,et al.  The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day , 2018, Journal of diabetes science and technology.